Corporate Finance

As FuelCell Energy eyes larger global projects, it hires a legal expert known for scaling power giants, signaling a strategic shift to execution.

With FDA alignment for its rapid postpartum depression therapy and new trials for anxiety, Reunion Neuroscience is pioneering a new era of mental health.

With key partners secured, Delfin Midstream is set to greenlight America's pioneering floating LNG project, reshaping the global energy map.

With pivotal cancer drug data looming and a new nuclear supply chain, Bicycle Therapeutics is betting big on its novel platform. Will 2026 be its breakout year?

WindRose and Francisco Partners invest in Avalon, signaling a major shift toward tech-driven management of the multi-billion dollar diagnostic testing market.

Princeton-based EDETEK will present its AI-powered clinical trial ecosystem at the J.P. Morgan conference, aiming to capture a slice of a booming market.

The firm gives bondholders more time to trade near-term notes for a higher yield, sparking debate on strategy versus necessity in a tough market.

Palladyne AI launches its IQ 2.0 software, a low-code platform aiming to overhaul defense manufacturing in line with new government mandates.

The burger chain posted positive sales and aggressive 2026 growth plans, navigating weather woes and inflation with new menu items and operational tweaks.

Amidst a strategic push for profitability, CytoSorbents advances its DrugSorb-ATR device, aiming to revolutionize safety in cardiac surgery.

Utz Brands posted strong 2025 profit growth and market share gains, overcoming retail inventory issues caused by economic headwinds like SNAP delays.

IVECO and PlusAI are deploying Level 4 autonomous trucks on a key Spanish freight corridor, heralding a new era for logistics in Southern Europe.

A new report names QuickBooks Payroll best for integrated time tracking, highlighting a major shift for businesses navigating complex labor laws in 2026.

As hockey costs soar, a corporate program backed by legends like Wickenheiser passes a major milestone, helping more Canadian kids get on the ice.

As AI accelerates software creation, TestMu AI (formerly LambdaTest) launches the first agentic quality platform to ensure quality keeps pace.

With new funding, Nanochon is advancing its 3D-printed Chondrograft™ implant, offering hope for faster recovery to patients with chronic knee damage.

Cytek Biosciences reports preliminary 2025 revenue of $201M, beating estimates with a major Q4 growth surge ahead of its key J.P. Morgan presentation.

CoinEx's consistent token burning removes over 166M CET in a year, signaling a long-term commitment to scarcity and value in a competitive market.

A Chinese manufacturer claims 25 years of experience in a bid to disrupt the $70B cosmetics OEM/ODM market, but can it rival established global titans?

Dolf van den Brink will step down in 2026 after a turbulent tenure, leaving an ambitious new strategy for his successor to execute amid market skepticism.